TD Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-62,946
| Closed | -$469K | – | 1231 |
|
|
2024
Q4 | $469K | Sell |
62,946
-42,000
| -40% | -$313K | ﹤0.01% | 1190 |
|
|
2024
Q3 | $837K | Sell |
104,946
-22,748
| -18% | -$182K | ﹤0.01% | 1221 |
|
|
2024
Q2 | $1.11M | Sell |
127,694
-15,200
| -11% | -$132K | ﹤0.01% | 1145 |
|
|
2024
Q1 | $2.95M | Hold |
142,894
| – | – | ﹤0.01% | 907 |
|
|
2023
Q4 | $3.3M | Buy |
142,894
+71,094
| +99% | +$1.64M | ﹤0.01% | 850 |
|
|
2023
Q3 | $574K | Buy |
+71,800
| New | +$574K | ﹤0.01% | 1243 |
|